digiMedical Solutions, Inc.(TM) Launches New Corporate Website Detailing Company's Digital Prescription Technology and

* Reuters is not responsible for the content in this press release.

Thu Mar 12, 2009 9:01am EDT

  COLLEYVILLE, TX, Mar 12 (MARKET WIRE) -- 
digiMedical Solutions, Inc.(TM) (PINKSHEETS: DGMS) today announced the
launch of a new interactive corporate website. The new site,
www.digimedical.com, offers doctors, patients, pharmacists and investors
a clear view of the company's technology, service offerings and current
news and events.

    digiMedical Solutions has a suite of proprietary and private labeled
digital prescription handling software, linking physicians to pharmacies
to improve prescription fulfillment security and expedite the prescription
fulfillment process. The company is targeting the medical industry with
three key software packages, digiRX(TM), digiReAuth(TM) and digiPRN(TM).
These three software packages and supporting services will handle the
prescription process, the refill and reauthorization process and network
security during fulfillment process.

    digiMedical Technologies

    Utilizing the latest Microsoft technologies such as .NET, AJAX and
Microsoft SQL, the Company has developed a suite of products to digitally
manage the prescription process. The company's products comply with all
HIPAA and DEA requirements for patient medical record security.


--  digiRX(TM) - Software to streamline and digitize the prescription
    handling process to eliminate handwritten errors, prescription loss,
    prescription forgery and improve the speed of patient information
    verification and prescription fulfillment.

--  digiReAuth(TM) - Prescription reauthorization software used in
    conjunction with the company's call center, to process patient prescription
    reauthorizations digitally between the clinic and pharmacy, reducing
    physician workload and speeding up the process for the patient.

--  digiPRN(TM) - Software connecting the Pharmacist to the Doctor's
    office for the process of receiving digital prescriptions. Pharmacists no
    longer need to worry about the security of the prescription since the
    doctor and pharmacist are on the same secure network.
    

    
To be added to digiMedical's corporate e-mail list to receive company
updates, please send an e-mail to ir@digimedical.com.

    About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)

    digiMedical Solutions, Inc.(TM) is a pharmacy and medical technology
company focused on developing next generation, digital medical technology
with an emphasis on digital prescriptions (d-Prescriptions) that closely
align the doctor, pharmacist and patient. The company's planned growth
will come from three channels: direct marketing of the company's wireless
based d-prescription technology to physicians, direct marketing of the
company's digital call center services for refills and reauthorization
and partnering with independent pharmacy chains to focus sales with the
technology suite.

    Forward-Looking Statement

    Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-Looking Statements
may be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission.

    

Contact:
digiMedical Solutions, Inc.
Investor Relations
214-722-3029
ir@digimedical.com
www.digimedical.com

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.